Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats

Abstract

Tissue protein hypercatabolism (TPH) is an important feature in cancer cachexia, particularly with regard to the skeletal muscle. The Yoshida AH-130 rat ascites hepatoma is a model system for studying the mechanisms involved in the processes that lead to tissue depletion, since it induces in the host a rapid and progressive muscle wasting, primarily due to TPH. The present study was aimed at investigating if IL-15, which is known to favour muscle fibre hypertrophy, could antagonize the enhanced muscle protein breakdown in this cancer cachexia model. Indeed, IL-15 treatment partly inhibited skeletal muscle wasting in AH-130-bearing rats by decreasing (8-fold) protein degradative rates (as measured by 14C-bicarbonate pre-loading of muscle proteins) to values even lower than those observed in non-tumour-bearing animals. These alterations in protein breakdown rates were associated with an inhibition of the ATP-ubiquitin-dependent proteolytic pathway (35% and 41% for 2.4 and 1.2 kb ubiquitin mRNA, and 57% for the C8 proteasome subunit, respectively). The cytokine did not modify the plasma levels of corticosterone and insulin in the tumour hosts. The present data give new insights into the mechanisms by which IL-15 exerts its preventive effect on muscle protein wasting and seem to warrant the implementation of experimental protocols involving the use of the cytokine in the treatment of pathological states characterized by TPH, particularly in skeletal muscle, such as in the present model of cancer cachexia.

References 52

1. 1.

   Akbar A. N., Borthwick N. J., Wickremasinghe R. G., Panayoitidis P., Pilling D., Bofill M., Krajewski S., Reed J. C., Salmon M. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol. 1996;26(2):294-299.

   Not in our library10.1002/eji.1830260204

2. 2.

   Albano J. D., Ekins R. P., Maritz G., Turner R. C. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh). 1972;70(3):487-509.

   Not in our library10.1530/acta.0.0700487

3. 3.

   Argilés J. M., López-Soriano F. J. The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci. 1996;17(6):223-226.

   Not in our library10.1016/0165-6147(96)10021-3

4. 4.

   Armitage R. J., Macduff B. M., Eisenman J., Paxton R., Grabstein K. H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol. 1995;154(2):483-490.

   Not in our library

5. 5.

   Baccino F. M., Tessitore L., Bonelli G., Isidoro C. Protein turnover states of tumour cells and host tissues in an experimental model. Biomed Biochim Acta. 1986;45(11-12):1585-1590.

   Not in our library

6. 6.

   Beck S. A., Smith K. L., Tisdale M. J. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 1991;51(22):6089-6093.

   Not in our library

7. 7.

   Beck S. A., Tisdale M. J. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res. 1989;49(14):3800-3804.

   Not in our library

8. 8.

   Bond U., Agell N., Haas A. L., Redman K., Schlesinger M. J. Ubiquitin in stressed chicken embryo fibroblasts. J Biol Chem. 1988;263(5):2384-2388.

   Not in our library

9. 9.

   Bond U., Schlesinger M. J. Ubiquitin is a heat shock protein in chicken embryo fibroblasts. Mol Cell Biol. 1985;5(5):949-956.

   Not in our library10.1128/mcb.5.5.949-956.1985

10. 10.

    Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.

    Not in our library10.1016/0003-2697(76)90527-3

11. 11.

    Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Rückert R., Krause H., Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med. 1997;3(10):1124-1128.

    Not in our library10.1038/nm1097-1124

12. 12.

    Burton J. D., Bamford R. N., Peters C., Grant A. J., Kurys G., Goldman C. K., Brennan J., Roessler E., Waldmann T. A. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994;91(11):4935-4939.

    Not in our library10.1073/pnas.91.11.4935

13. 13.

    Carbó N., Costelli P., Tessitore L., Bagby G. J., López-Soriano F. J., Baccino F. M., Argilés J. M. Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond). 1994;87(3):349-355.

    Not in our library10.1042/cs0870349

14. 14.

    Carson W. E., Fehniger T. A., Haldar S., Eckhert K., Lindemann M. J., Lai C. F., Croce C. M., Baumann H., Caligiuri M. A. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest. 1997;99(5):937-943.

    Not in our library10.1172/jci119258

15. 15.

    Carson W. E., Giri J. G., Lindemann M. J., Linett M. L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caligiuri M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994;180(4):1395-1403.

    Not in our library10.1084/jem.180.4.1395

16. 16.

    Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156-159.

    Not in our library10.1006/abio.1987.9999

17. 17.

    Ciechanover A., Finley D., Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell. 1984;37(1):57-66.

    Not in our library10.1016/0092-8674(84)90300-3

18. 18.

    Costelli P., Carbó N., Tessitore L., Bagby G. J., Lopez-Soriano F. J., Argilés J. M., Baccino F. M. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest. 1993;92(6):2783-2789.

    Not in our library10.1172/jci116897

19. 19.

    Costelli P., García-Martínez C., Llovera M., Carbó N., López-Soriano F. J., Agell N., Tessitore L., Baccino F. M., Argilés J. M. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest. 1995;95(5):2367-2372.

    Not in our library10.1172/jci117929

20. 20.

    Dessí S., Batetta B., Anchisi C., Pani P., Costelli P., Tessitore L., Baccino F. M. Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer. 1992;66(5):787-793.

    Not in our library10.1038/bjc.1992.361

21. 21.

    García-Martínez C., López-Soriano F. J., Argilés J. M. Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem. 1993;125(1):11-18.

    Not in our library10.1007/bf00926829

22. 22.

    Garlick P. J., Millward D. J., James W. P., Waterlow J. C. The effect of protein deprivation and starvation on the rate of protein synthesis in tissues of the rat. Biochim Biophys Acta. 1975;414(1):71-84.

    Not in our library10.1016/0005-2787(75)90126-4

23. 23.

    Girard D., Paquet M. E., Paquin R., Beaulieu A. D. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood. 1996;88(8):3176-3184.

    Not in our library

24. 24.

    Giri J. G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L. S., Cosman D., Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994;13(12):2822-2830.

    Not in our library10.1002/j.1460-2075.1994.tb06576.x

25. 25.

    Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994;264(5161):965-968.

    Not in our library10.1126/science.8178155

26. 26.

    Hilenski L. L., Terracio L., Haas A. L., Borg T. K. Immunolocalization of ubiquitin conjugates at Z-bands and intercalated discs of rat cardiomyocytes in vitro and in vivo. J Histochem Cytochem. 1992;40(7):1037-1042.

    Not in our library10.1177/40.7.1318894

27. 27.

    Kien C. L., Camitta B. M. Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia. JPEN J Parenter Enteral Nutr. 1987;11(2):129-134.

    Not in our library10.1177/0148607187011002129

28. 28.

    Kien C. L., Camitta B. M. Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma. Cancer Res. 1983;43(11):5586-5592.

    Not in our library

29. 29.

    Lawson D. H., Richmond A., Nixon D. W., Rudman D. Metabolic approaches to cancer cachexia. Annu Rev Nutr. 1982;2:277-301.

    Not in our library10.1146/annurev.nu.02.070182.001425

30. 30.

    Llovera M., Garcia-Martinez C., Agell N., Lopez-Soriano F. J., Argiles J. M. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer. 1995;61(1):138-141.

    Not in our library10.1002/ijc.2910610123

31. 31.

    Llovera M., García-Martínez C., Agell N., Marzábal M., López-Soriano F. J., Argilés J. M. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett. 1994;338(3):311-318.

    Not in our library10.1016/0014-5793(94)80290-4

32. 32.

    Llovera M., López-Soriano F. J., Argilés J. M. Chronic tumour necrosis factor-alpha treatment modifies protein turnover in rat tissues. Biochem Mol Biol Int. 1993;30(1):29-36.

    Not in our library

33. 33.

    Llovera M., López-Soriano F. J., Argilés J. M. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst. 1993;85(16):1334-1339.

    Not in our library10.1093/jnci/85.16.1334

34. 34.

    Lowell B. B., Ruderman N. B., Goodman M. N. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J. 1986;234(1):237-240.

    Not in our library10.1042/bj2340237

35. 35.

    Lundholm K., Ekman L., Edström S., Karlberg I., Jagenburg R., Scherstén T. Protein synthesis in liver tissue under the influence of a methylcholanthrene-induced sarcoma in mice. Cancer Res. 1979;39(11):4657-4661.

    Not in our library

36. 36.

    Melville S., McNurlan M. A., Calder A. G., Garlick P. J. Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer. Cancer Res. 1990;50(4):1125-1131.

    Not in our library

37. 37.

    Moley J. F., Morrison S. D., Gorschboth C. M., Norton J. A. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin. Cancer Res. 1988;48(10):2784-2787.

    Not in our library

38. 38.

    Munger W., DeJoy S. Q., Jeyaseelan R., Torley L. W., Grabstein K. H., Eisenmann J., Paxton R., Cox T., Wick M. M., Kerwar S. S. Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell Immunol. 1995;165(2):289-293.

    Not in our library10.1006/cimm.1995.1216

39. 39.

    Pain V. M., Randall D. P., Garlick P. J. Protein synthesis in liver and skeletal muscle of mice bearing an ascites tumor. Cancer Res. 1984;44(3):1054-1057.

    Not in our library

40. 40.

    Popp M. B., Wagner S. C., Enrione E. B., Brito O. J. Host and tumor responses to varying rates of nitrogen infusion in the tumor-bearing rat. Ann Surg. 1988;207(1):80-89.

    Not in our library10.1097/00000658-198801000-00016

41. 41.

    Quinn L. S., Haugk K. L., Grabstein K. H. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology. 1995;136(8):3669-3672.

    Not in our library10.1210/endo.136.8.7628408

42. 42.

    Reinecker H. C., MacDermott R. P., Mirau S., Dignass A., Podolsky D. K. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology. 1996;111(6):1706-1713.

    Not in our library10.1016/s0016-5085(96)70036-7

43. 43.

    Shaw J. H., Wolfe R. R. Whole-body protein kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion and total parenteral nutrition. Surgery. 1988;103(2):148-155.

    Not in our library

44. 44.

    Tanaka K., Kanayama H., Tamura T., Lee D. H., Kumatori A., Fujiwara T., Ichihara A., Tokunaga F., Aruga R., Iwanaga S. cDNA cloning and sequencing of component C8 of proteasomes from rat hepatoma cells. Biochem Biophys Res Commun. 1990;171(2):676-683.

    Not in our library10.1016/0006-291x(90)91199-3

45. 45.

    Tayek J. A., Istfan N. W., Jones C. T., Hamawy K. J., Bistrian B. R., Blackburn G. L. Influence of the Walker 256 carcinosarcoma on muscle, tumor, and whole-body protein synthesis and growth rate in the cancer-bearing rat. Cancer Res. 1986;46(11):5649-5654.

    Not in our library

46. 46.

    Tessitore L., Bonelli G., Baccino F. M. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J. 1987;241(1):153-159.

    Not in our library10.1042/bj2410153

47. 47.

    Tessitore L., Bonelli G., Cecchini G., Amenta J. S., Baccino F. M. Regulation of protein turnover versus growth state: ascites hepatoma as a model for studies both in the animal and in vitro. Arch Biochem Biophys. 1987;255(2):372-384.

    Not in our library10.1016/0003-9861(87)90405-x

48. 48.

    Tessitore L., Bonelli G., Isidoro C., Kazakova O. V., Baccino F. M. Comparative studies on protein turnover regulations in tumor cells and host tissues: development and analysis of an experimental model. Toxicol Pathol. 1986;14(4):451-456.

    Not in our library10.1177/019262338601400411

49. 49.

    Tessitore L., Costelli P., Baccino F. M. Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer. 1993;67(1):15-23.

    Not in our library10.1038/bjc.1993.4

50. 50.

    Tessitore L., Costelli P., Baccino F. M. Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J. 1994;299(Pt 1):71-78.

    Not in our library10.1042/bj2990071

51. 51.

    Tessitore L., Costelli P., Bonetti G., Baccino F. M. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Arch Biochem Biophys. 1993;306(1):52-58.

    Not in our library10.1006/abbi.1993.1479

52. 52.

    Tisdale M. J. Cancer cachexia. Br J Cancer. 1991;63(3):337-342.

    Not in our library10.1038/bjc.1991.80

Cited by papers we hold 3

• Role of Myokines in Regulating Skeletal Muscle Mass and Function · 2019
  No notice
• Effects of Resistance Exercise and Fermented Soybean Consumption on Glucose Tolerance and Expressions of Immune Senescence-Related Myokines in Middle-Aged Obese Rats · 2018
  Not checked
• Sarcopenia, obesity, and natural killer cell immune senescence in aging: Altered cytokine levels as a common mechanism · 2012
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.